Quest Diagnostics (NYSE:DGX) was upgraded by equities research analysts at EVA Dimensions from a “hold” rating to a “buy” rating in a research note issued to investors on Tuesday, American Banking & Market News reports. Quest Diagnostics Inc (NYSE:DGX) shares after opening at $58.50 moved to $60.50 on last trade day and at the end of the day closed at $57.99. Company price to sales ratio in past twelve months was calculated as 1.18 and price to cash ratio as 45.28. Quest Diagnostics Inc (NYSE:DGX) showed a positive weekly performance of 3.91%.
Steelcase Inc. (NYSE:SCS) issued an update on its first quarter earnings guidance on Tuesday morning. The company provided EPS guidance of $0.14 to $0.17 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.16, StockRatingsNetworkreports. The company issued revenue guidance of $715 to $740, compared to the consensus revenue estimate of $700.00 million. Steelcase Inc. (NYSE:SCS) shares advanced 11.66% in last trading session and ended the day on $16.28. SCS return on equity ratio is recorded as 5.40% and its return on assets is 2.10%. Steelcase Inc. (NYSE:SCS) yearly performance is 10.90%.
Movado Group, Inc (NYSE:MOV) reported booming sales and strong fourth-quarter profits, as well as issuing a positive forecast and increasing its shareholder dividend. The New Jersey-based watch maker has been putting the finishing touches on a turnaround for several quarters now. Movado Group, Inc (NYSE:MOV) shares moved up 10.18% in last trading session and was closed at $46.31, while trading in range of $45.43-$48.27. Movado Group, Inc (NYSE:MOV) year to date performance is 5.23%.
Equities researchers at Aegis boosted their price objective on shares of China Cord Blood (NYSE:CO) from $5.00 to $7.00 in a research report issued on Tuesday, AR Network reports. The firm currently has a “buy” rating on the stock. Aegis’ target price suggests a potential upside of 66.67% from the stock’s previous close. China Cord Blood Corp (NYSE:CO) weekly performance is 2.14%. On last trading day company shares ended up $4.29. China Cord Blood Corp (NYSE:CO) distance from 50-day simple moving average is 5.18%. Analysts mean target price for the company is $6.00.